SyntheticMR announced that they have reached an agreement with one of their partners. This signed agreement means a commitment that the product package SyMRI NEURO will be sold globally in a significant volume. The agreement has great strategic value for the company and the sales value amounts to at least SEK 15 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27.7 SEK | +1.09% | -.--% | +4.14% |
05-22 | SyntheticMR AB Announces Board Changes | CI |
05-21 | SyntheticMR AB Provides Earnings Guidance for the Year 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.14% | 109M | |
-4.94% | 29.58B | |
+49.49% | 9.98B | |
+34.36% | 4.4B | |
-42.11% | 2.19B | |
-9.44% | 1.6B | |
-28.06% | 1.24B | |
-42.92% | 978M | |
+8.65% | 972M | |
-47.18% | 735M |
- Stock Market
- Equities
- SYNT Stock
- News SyntheticMR AB
- SyntheticMR Signs Sales Agreement Regarding SyMRI NEURO